Airway bacterial colonization: The missing link between COPD and cardiovascular events?

Respiratory Medicine

Volumn 106, Issue 7, 2012, Pages 915-923

  Fuschillo, Salvatore ^a   Martucci, Michele ^a   Donner, Claudio F ^b   Balzano, Giovanni ^a  

^a IRCCS   (Italy)

^b Mondo Medico   (Italy)

Author keywords

Atherosclerosis; Bacterial colonization; Chronic obstructive pulmonary disease; Endothelial dysfunction; Systemic inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ARTERIAL STIFFNESS; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL COLONIZATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHLAMYDOPHILA PNEUMONIAE; CHRONIC BRONCHITIS; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ENDOTHELIAL DYSFUNCTION; ENTEROBACTERIACEAE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS HAEMOLYTICUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MORAXELLA CATARRHALIS; MORBIDITY; MORTALITY; MYCOPLASMA PNEUMONIAE; NEISSERIA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; ATHEROSCLEROSIS; BACTERIAL INFECTIONS; BRONCHI; CARDIOVASCULAR DISEASES; CYTOKINES; ENDOTHELIUM, VASCULAR; FORECASTING; HUMANS; MICE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84861195530     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.03.023     Document Type: Review

References (104)

1. D.M. Mannino, D.M. Homa, L.J. Akinbami, E.S. Ford, and S.C. Redd Chronic obstructive pulmonary disease surveillance: United States, 1971-2000 MMWR Surveill Summ 51 2002 1 16
2. S.D. Sullivan, S.D. Ramsey, and T.A. Lee The economic burden of COPD Chest 117 2000 5S 9S (Pubitemid 30111556)
3. J.C. Chen, and D.M. Mannino Worldwide epidemiology of chronic obstructive pulmonary disease Curr Opin Pulm Med 5 1999 93 99
4. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, N.R. Rodriguez-Roisi, C. van Weel, and J. Zielinski Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555 (Pubitemid 47403272)
5. D.D. Sin, and S.F.P. Man Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease Can J Physiol Pharmacol 83 2005 8 13 (Pubitemid 40754770)
6. D. Serapinas, A. Narbekovas, J. Juskevicius, and R. Sakalauskas Systemic inflammation in COPD in relation to smoking status Multidiscip Resp Med 6 2011 214 219
7. C.F. Donner, and L. Bjermer Clinical commentary - COPD is not a systemic disease. Results from AIMAR Expert Opinion Consensus/Dissensus Seminar "COPD is/is not a systemic disease?", Venice, Italy, 13-14 November 2008. Respir Med vol. 103 2009 pp. 1270-1275
8. E.F. Wouters Chronic obstructive pulmonary disease: 5. Systemic effects of COPD Thorax 57 2002 1067 1070 (Pubitemid 35440768)
9. D.D. Sin, J.P. Man, and S.F.P. Man The risk of osteoporosis in Caucasian men and women with obstructive airways disease Am J Med 114 2003 10 14 (Pubitemid 36126509)
10. D.J. Hole, G.C. Watt, G. Davey-Smith, C.L. Hart, C.R. Gillis, and V.M. Hawthorne Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study BMJ 313 1996 711 715
11. L.M. Fabbri, F. Luppi, B. Beghé, and K.F. Rabe Complex chronic comorbidities of COPD Eur Respir J 31 2008 204 212
12. E.F.M. Wouters Local and systemic inflammation in chronic obstructive pulmonary disease Proc Am Thorac Soc 2 2005 6 33
13. J. Gea, E. Barreiro, and M. Orozco-Levi Systemic inflammation in COPD Clin Pulm Med 16 2009 233 242
14. N. Sarioglu, A.O. Alpaydin, A.S. Coskun, P. Celik, B.C. Ozyurt, and A. Yorgancioglu Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients Multidiscip Resp Med 5 2010 84 91
15. W.R. Perera, J.R. Hurst, T.M.A. Wilkinson, R.J. Sapsford, H. Mullerova, G.C. Donaldson, and J.A. Wedzicha Inflammatory changes, recovery and recurrence at COPD exacerbation Eur Respir J 29 2007 527 534 (Pubitemid 46372101)
16. J.A. Wedzicha Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1757 1760
17. T.A.R. Seemungal, G.C. Donaldson, E.A. Paul, J.C. Bestall, D.J. Jeffries, and J.A. Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1418 1422
18. G.C. Donaldson, T.A.R. Seemungal, A. Browmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852 (Pubitemid 35178607)
19. M. Solèr Modulation of airway inflammation to prevent exacerbations of COPD Eur Respir Rev 14 2005 78 82 (Pubitemid 43028777)
20. S. Sethi, and T.F. Murphy Infection in the pathogenesis and course of chronic obstructive pulmonary disease N Engl J Med 359 2008 2355 2365
21. T.F. Murphy, A.L. Brauer, A.T. Schiffmacher, and S. Sethi Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 266 272 (Pubitemid 38971411)
22. N. Soler, S. Ewig, A. Torres, A. Filella, J. Gonzales, and A. Zaubet Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease Eur Respir J 14 1999 1015 1022
23. R. Wilson Bacteria and airway inflammation in chronic obstructive pulmonary disease. More evidence Am J Respir Crit Care Med 172 2005 147 148 (Pubitemid 40981186)
24. A. Bhowmik, T.A.R. Seemungal, R.J. Sapsford, and J.A. Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax 55 2000 114 120 (Pubitemid 30245950)
25. D. Banerjee, O.A. Khair, and D. Honeybourne Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD patients Eur Respir J 23 2004 685 691 (Pubitemid 38618136)
26. J.A. Wedzicha, T.A. Seemungal, P.K. MacCallum, E.A. Paul, G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and T.W. Meade Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels Thromb Haemost 84 2000 210 215 (Pubitemid 30601465)
27. S. Gompertz, C. O'brien, Bayley Dl, S.L. Hill, and R.A. Stockley Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Eur Respir J 17 2001 1112 1119 (Pubitemid 32717466)
28. E. Bathoorn, J.J.W. Liesker, D.S. Postma, G.H. Koeter, M. van der Toorn, S. van der Heide, H.A. Ross, A.J.M. vanOosterhout, and H.A.M. Kerstjens Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation Int J Chron Obstruct Pulmon Dis 4 2009 101 109
29. E.F.M. Wouters, K.H. Groenewegen, M.A. Dentener, and J.H.J. Vernooy Systemic inflammation in chronic obstructive pulmonary disease. The role of exacerbations Proc Am Thorac Soc 4 2007 626 634 (Pubitemid 350291625)
30. J.R. Hurst, W.R. Perera, T.M.A. Wilkinson, G.C. Donaldson, and J.A. Wedzicha Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 173 2006 71 78 (Pubitemid 43069790)
31. N.L. Mills, J.J. Miller, A. Anand, S.D. Robinson, G.A. Frazer, D. Anderson, L. Breen, I.B. Wilkinson, C.M. McEniery, K. Donaldson, D.E. Newby, and W. MacNee Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk Thorax 63 2008 306 311 (Pubitemid 351497941)
32. D.D. Sin, L.L. Wu, and S.F.P. Man The relationship between reduced lung function and cardiovascular mortality. A population-based study and a systematic review of the literature Chest 127 2005 1952 1959
33. N.R. Anthonisen, J.E. Connett, P.L. Enright, J. Manfreda Lung Health Study Research Group Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 166 2002 333 339 (Pubitemid 34864422)
34. M.H. Shishehbor, and D.L. Bhatt Inflammation and atherosclerosis Curr Atheroscler Rep 6 2004 131 139 (Pubitemid 38914958)
35. A.E. Camilli, D.R. Robbins, and M.D. Lebowitz Death certificate reporting of confirmed airways obstructive disease Am J Epidemiol 133 1991 795 800
36. L. Huiart, P. Ernst, and S. Suisse Cardiovascular morbidity and mortality in COPD Chest 128 2005 2640 2646 (Pubitemid 41507622)
37. Wise RA, McGarvey LP, John M, Anderson JA, Zvarich MT. Reliability of cause-specific mortality adjudication in a COPD clinical trial. Program and abstracts of the American Thoracic Society 2006 International Conference; May 19-24, 2006; San Diego, California.
38. E.B. Schroeder, V.L. Welch, D. Couper, F.J. Nieto, D. Liao, W.D. Rosamond, and G. Heiss Lung function and incident coronary heart disease. The atherosclerosis risk in communities study Am J Epidemol 158 2003 1171 1181 (Pubitemid 37548787)
39. C. Persson, C. Bengtsson, L. Lapidus, E. Rybo, G. Thiringer, and H. Wedfel Peak expiratory flow and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg Sweden Am J Epidemiol 124 1986 942 948 (Pubitemid 17207262)
40. P.D. Sorlie, W.B. Kannel, and G. O'Connor Mortality associated with respiratory function and symptoms in advanced age. The Framingham study Am Rev Respir Dis 140 1989 379 384 (Pubitemid 19218353)
41. P. Jousilathi, E. Vartiainen, J. Toumilehto, and P. Puska Symptoms of chronic bronchitis and the risk of coronary disease The Lancet 348 9027 1996 567 572 (Pubitemid 26283887)
42. A. Rosengren, and L. Wilhelmsen Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men Int J Epidemiol 27 1998 962 969 (Pubitemid 29026745)
43. P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 2003 672 688 (Pubitemid 37258549)
44. W. MacNee Oxidants/antioxidants and COPD Chest 117 2000 303S 317S (Pubitemid 30327005)
45. R. Tkacova, Z. Kluchova, P. Joppa, D. Petrasova, and A. Molconyiova Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Respir Med 101 2007 1670 1676 (Pubitemid 46930714)
46. I. Rahman, D. Morrison, K. Donaldson, and W. MacNee Systemic oxidative stress in asthma, COPD, and smokers Am J Respir Crit Care Med 154 1996 1055 1060
47. E.M. Drost, K.M. Skwarski, J. Sauleda, N. Soler, J. Roca, A. Agustì, and W. MacNee Oxidative stress and airway inflammation in severe exacerbations of COPD Thorax 60 2005 293 300 (Pubitemid 40522365)
48. W. Droge Free radicals in the physiological control of cell function Physiol Rev 82 2002 47 95 (Pubitemid 34654215)
49. A.R. Weseler, and A. Bast Oxidative stress and vascular function: implications for pharmacologic treatments Curr Hypertens Rep 12 2010 154 161
50. M.A. Victor, M. Rocha, E. Solá, C. Bañuls, K. Garcia-Malpartida, and A. Hernández-Mijares Oxidative stress, endothelial dysfunction and atherosclerosis Curr Pharm Des 15 2009 2988 3002
51. V.I. Peinado, J.A. Barbera, J. Ramirez, F.P. Gomez, J. Roca, L. Jover, J.M. Gimferrer, and R. Rodriguez-Roisin Endothelial dysfunction in pulmonary arteries of patients with mild COPD Am J Physiol 274 1998 L908 L913
52. J.F. Arnal, A.T. Dinh-Xuan, M. Pueyo, B. Darblade, and J. Rami Endothelium-derived nitric oxide and vascular physiology and pathology Cell Mol Life Sci 55 1999 1078 1087 (Pubitemid 29361074)
53. E. Karatzis The role of inflammatory agents in endothelial function and their contribution to atherosclerosis Hell J Cardiol 46 2005 232 239 (Pubitemid 41664060)
54. R.G. Barr, S. Mesia-Vela, J.H. Austin, R.C. Basner, B.M. Keller, A.P. Reeves, D. Shimbo, and L. Stevenson Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study Am J Respir Crit Care Med 176 2007 1200 1207 (Pubitemid 350256473)
55. P. Eickoff, A. Valipour, D. Kiss, M. Schreder, L. Cekici, K. Geyer, R. Kohansal, and O.C. Burghuber Determinants of systemic vascular function in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 178 2008 1211 1218
56. B. Özben, E. Eryuksel, A.M. Tanzikulu, N. Papila-Topal, T. Çelikl, and Y. Baçaran Acute exacerbation impairs endothelial function in patients with chronic obstructive pulmonary disease Arch Turk Soc Cardiol 38 2010 1 7
57. C.G. Schalkwijk, D.C. Poland, W. van Dijk, A. Kpk, J.J. Emeis, A.M. Drager, A. Doni, V.W. van Hinsbergh, and C.D. Stehouwer Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation Diabetologia 42 1999 351 357 (Pubitemid 29111443)
58. S.J. Cleland, N. Sattar, J.R. Petrie, N.G. Forouhi, H.L. Elliott, and G.M. Connell Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease Clin Sci (London) 98 5 2000 531 535 (Pubitemid 30261001)
59. S. Verma, C.H. Wang, S.H. Li, A.S. Dumont, P.W. Fedak, M.W. Badiwala, B. Dhillon, R.D. Weisel, R.-K. Li, D.A.G. Mickle, and D.J. Stewart A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919 (Pubitemid 34925323)
60. R. Sabit, C.E. Bolton, P.H. Edwards, R.J. Pettit, W.D. Evans, C.M. McEniery, I.B. Wilkinson, J.R. Cockcroft, and D.J. Shale Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 2007 1259 1265 (Pubitemid 46905751)
61. D.A. McAllister, J.D. Maclay, N.L. Mills, G. Mair, J. Miller, D. Anderson, D.E. Newby, J.T. Murchison, and W. MacNee Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 2007 1208 1214 (Pubitemid 350256474)
62. F.U. Mattace-Raso, T.J. van der Cammen, I.M. van der Meer, M.A. Schalekamp, R. Asmar, A. Hofman, and J.C. Witteman C-reactive protein and arterial stiffness in older adults: the Rotterdam Study Atherosclerosis 176 2004 111 116 (Pubitemid 39078652)
63. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
64. A.J. Luis Atheroslerosis. Nature 407 2000 233 241
65. W. MacNee, J. Maclay, and D. McAllister Cardiovascular injury and repair in chronic obstructive pulmonary disease Proc Am Thorac Soc 5 2008 824 833
66. M. Mahmoudi, N. Curzen, and P.J. Gallagher Atherogenesis: the role of inflammation and infection Hystopathology 50 2007 535 546 (Pubitemid 46495812)
67. S. Verma, S.H. Li, M.V. Badiwala, R.D. Weisel, P.W. Fedak, R.K. Li, B. Dhillon, and D.A. Mickle Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896 (Pubitemid 34437614)
68. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
69. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369 (Pubitemid 36158034)
70. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111 (Pubitemid 40776595)
71. R. Zhang, M.L. Brennan, Z. Shen, J.C. MacPherson, D. Schmitt, C.E. Molenda, and S.L. Hazen Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation J Biol Chem 277 2002 46116 46122 (Pubitemid 35417600)
72. R. Zhang, M.L. Brennan, X. Fu, R.J. Aviles, G.L. Pearce, M.S. Penn, E.J. Topol, D.L. Sprecher, and S.L. Hazen Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142 (Pubitemid 34041599)
73. E.A. Podrez, H.M. Abu-Soud, and S.L. Hazen Myeloperoxidase-generated oxidants and atherosclerosis Free Radic Biol Med 28 2000 1717 1725 (Pubitemid 30628658)
74. S. Kiechl, P. Werner, G. Egger, F. Oberhollenzer, M. Mayr, and Q. Xu PoeweW, Willeit J. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis. Prospective results from the Bruneck study Stroke 33 2002 2170 2176 (Pubitemid 35014624)
75. S.E. Epstein, Y.F. Zhou, and J. Zhu Infection and atherosclerosis: emerging mechanistic paradigms Circulation 100 1999 e20 e28
76. S.E. Epstein The multiple mechanisms by which infection may contribute to atherosclerosis development and course Circ Res 90 2002 2 4 (Pubitemid 34074598)
77. F.J. Nieto, E. Adam, P. Sorlie, H. Farzadegan, J.L. Melnick, G.W. Comstock, and M. Szklo Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis Circulation 94 1996 922 927 (Pubitemid 26292841)
78. J.B. Muhlestein, B.D. Horne, J.F. Carlquist, Carlquist, T.E. Madsen, T.L. Bair, R.R. Pearson, and J.L. Anderson Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease Circulation 102 2000 1917 1923
79. J. Zhu, A.A. Quyyumi, J.E. Norman, R. Costello, G. Csako, and S.E. Epstain The possible role of hepatitis A virus in the pathogenesis of atherosclerosis J Infect Dis 182 2000 1583 1587
80. R. Dechend, M. Maass, J. Gieffers, R. Diez, C. Scheidereit, A. Leutz, and M.D. Gulba Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-B and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis Circulation 100 1999 1369 1373 (Pubitemid 29451694)
81. P. Liuba, P. Karnani, E. Pesonen, I. Paakkari, A. Forslid, K. Persson, T. Wadstrom, and R. Laurini Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice Circulation 102 2000 1039 1044 (Pubitemid 30656012)
82. L. Tormakangas, L. Erkkila, T. Korhonen, T. Tiirola, A. Bloigu, P. Saikku, and A. Lainonen Effects of repeated Chalamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice Infect Immun 73 2005 6458 6466 (Pubitemid 41368807)
83. Espinola-Klein, H.J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, A. Victor, G. Hafner, W. Schlumberger, J. Meyer for the AtheroGene Investigators Impact of pathogen burden on extent and long-term prognosis of atherosclerosis Circulation 105 2002 15 21 (Pubitemid 34049136)
84. S.E. Epstain, J. Zhu, M.S. Burnett, Y.F. Zhou, G. Vercellotti, and D. Hajjar Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry Arterioscler Thromb Vasc Biol 20 2000 1417 1420 (Pubitemid 30353867)
85. J. Zhu, A.A. Quyyumi, J.E. Norman, G. Csako, M.A. Waclawiw, G.M. Shearer, J.T. Grayston, and S.E. Epstein Total pathogen burden contributes incrementally to coronary artery disease risk and to C-reactive protein levels Am J Cardiol 85 2000 140 146 (Pubitemid 30026092)
86. A. Prasad, J. Zhu, J.P.J. Halcox, M.A. Waclawiw, S.E. Epstein, and A.A. Quyyumi Predisposition to atherosclerosis by infections. Role of endothelial dysfunction Circulation 106 2002 184 190 (Pubitemid 34761297)
87. M. Leinonen, and P. Saikku Evidences for infectious agents in cardiovascular disease and atherosclerosis Lancet Infect Dis 2 2002 11 17 (Pubitemid 36109301)
88. G. Wick, M. Romen, A. Amberger, B. Metzler, M. Mayr, G. Falkensammer, and Q. Xu Atherosclerosis, autoimmunity and vascular-associated lymphoid tissue (VALT) FASEB J 11 1997 1199 1207 (Pubitemid 27481444)
89. J. Zhu, R.J. Katz, A.A. Quyyumi, D.A. Canos, D. Rott, G. Csako, A. Zalles-Ganley, J. Ogunmakinwa, A.G. Wasserman, and S.E. Epstein Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis Circulation 109 2004 36 41 (Pubitemid 38056018)
90. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Müllerova, R. Tal-Singer, B. Miller, D.A. Lomas, A. Agusti, W. MacNee, P. Calverley, S. Rennard, E.F.M. Wouters, and J.A. Wedzicha Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138
91. S. Sethi, R. Sethi, K. Eschberger, P. Lobbins, X. Cai, B.J.B. Grant, and T.F. Murphy Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 2007 356 361 (Pubitemid 47267469)
92. S. Sethi, N. Evans, B.J.B. Grant, and T.F. Murphy New strains of bacteria and exacerbations of chronic obstructive pulmonary disease N Engl J Med 347 2002 465 471 (Pubitemid 34879333)
93. R. Pela, F. Marchesai, C. Agostinelli, D. Staccioli, L. Cecarini, C. Bassotti, and C.M. Sanguinetti Airway microbial flora in COPD patients in stable conditions and during exacerbations: a bronchoscopic investigation Monaldi Arch Chest Dis 53 1998 262 267 (Pubitemid 28461652)
94. E. Monso, A. Rosell, G. Bonet, J. Manterola, P.J. Cardona, J. Ruiz, and J. Morena Risk factors for lower airway bacterial colonization in chronic bronchitis Eur Respir J 13 1999 338 342 (Pubitemid 29086830)
95. T.F. Murphy, A.L. Brauer, S. Sethi, M. Kilian, X. Cai, and A.J. Lesse Haemophilus haemoliticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae J Infect Dis 195 2007 81 89 (Pubitemid 44958229)
96. R. Bals, and P.S. Hiemstra Innate immunity in the lung: how epithelial cells fight against respiratory pathogens Eur Respir J 23 2004 327 333 (Pubitemid 38195522)
97. B. Opitz, V. van Laak, J. Eitel, and N. Suttorp Innate immune recognition in infections and non-infectious diseases of the lungs Am J Respir Crit Care Med 181 2010 1294 1309
98. D. Droemann, T. Goldmann, T. Tiedje, P. Zabel, K. Dalhoff, and B. Schaaf Toll-like receptors 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients Respir Res 6 2005 68
99. A.T. Hill, E.J. Campbell, S.L. Hill, D.L. Bayley, and R.A. Stockley Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis Am J Med 109 2000 288 295
100. P. Bresser, T.A. Out, L. van Alphen, H.M. Jansen, and R. Lutter Airway inflammation in non obstructive and obstructive chronic bronchitis with Haemophilus influenzae airway infection: comparison with non infected patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 947 952
101. S. Sethi, C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T.F. Murphy Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 491 497 (Pubitemid 351442187)
102. T.A.R. Seemungal, G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha Time course and recovery of exacerbations in patients with COPD Am J Respir Crit Care Med 161 2000 1608 1613
103. I.A. Ku, J.B. Imboden, P.Y. Hsue, and P. Ganz Rheumatoid arthritis. A model of systemic inflammation driving atherosclerosis Circ J 73 2009 977 985
104. F. Andersson, S. Borg, A.C. Jansson, A. Ericsson, C. Prutz, E. Ronmark, and B. Lundback The costs of exacerbations in chronic obstructive pulmonary disease (COPD) Respir Med 96 2002 700 708